BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 22138896)

  • 1. New organoruthenium complexes with bioactive thiosemicarbazones as co-ligands: potential anti-trypanosomal agents.
    Demoro B; Sarniguet C; Sánchez-Delgado R; Rossi M; Liebowitz D; Caruso F; Olea-Azar C; Moreno V; Medeiros A; Comini MA; Otero L; Gambino D
    Dalton Trans; 2012 Feb; 41(5):1534-43. PubMed ID: 22138896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential mechanism of the anti-trypanosomal activity of organoruthenium complexes with bioactive thiosemicarbazones.
    Demoro B; Rossi M; Caruso F; Liebowitz D; Olea-Azar C; Kemmerling U; Maya JD; Guiset H; Moreno V; Pizzo C; Mahler G; Otero L; Gambino D
    Biol Trace Elem Res; 2013 Jun; 153(1-3):371-81. PubMed ID: 23564472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multifunctional Organometallic Compounds Active against Infective Trypanosomes: Ru(II) Ferrocenyl Derivatives with Two Different Bioactive Ligands.
    Rivas F; Del Mármol C; Scalese G; Pérez Díaz L; Machado I; Blacque O; Salazar F; Coitiño EL; Benítez D; Medeiros A; Comini M; Gambino D
    Inorg Chem; 2024 Jun; 63(25):11667-11687. PubMed ID: 38860314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel ruthenium(II) cyclopentadienyl thiosemicarbazone compounds with antiproliferative activity on pathogenic trypanosomatid parasites.
    Fernández M; Arce ER; Sarniguet C; Morais TS; Tomaz AI; Azar CO; Figueroa R; Diego Maya J; Medeiros A; Comini M; Helena Garcia M; Otero L; Gambino D
    J Inorg Biochem; 2015 Dec; 153():306-314. PubMed ID: 26275470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-trypanosomal activity of doubly modified salinomycin derivatives.
    Antoszczak M; Steverding D; Sulik M; Janczak J; Huczyński A
    Eur J Med Chem; 2019 Jul; 173():90-98. PubMed ID: 30986574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New multifunctional Ru(II) organometallic compounds show activity against Trypanosoma brucei and Leishmania infantum.
    Rivas F; Del Mármol C; Scalese G; Pérez-Díaz L; Machado I; Blacque O; Medeiros A; Comini M; Gambino D
    J Inorg Biochem; 2022 Dec; 237():112016. PubMed ID: 36244312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New heterobimetallic ferrocenyl derivatives are promising antitrypanosomal agents.
    Rodríguez Arce E; Putzu E; Lapier M; Maya JD; Olea Azar C; Echeverría GA; Piro OE; Medeiros A; Sardi F; Comini M; Risi G; Salinas G; Correia I; Pessoa JC; Otero L; Gambino D
    Dalton Trans; 2019 Jun; 48(22):7644-7658. PubMed ID: 31049548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 9- and 11-Substituted 4-azapaullones are potent and selective inhibitors of African trypanosoma.
    Maiwald F; Benítez D; Charquero D; Dar MA; Erdmann H; Preu L; Koch O; Hölscher C; Loaëc N; Meijer L; Comini MA; Kunick C
    Eur J Med Chem; 2014 Aug; 83():274-83. PubMed ID: 24973661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Singly and doubly modified analogues of C20-epi-salinomycin: A new group of antiparasitic agents against Trypanosoma brucei.
    Czerwonka D; Barcelos Y; Steverding D; Cioch A; Huczyński A; Antoszczak M
    Eur J Med Chem; 2021 Jan; 209():112900. PubMed ID: 33071053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of selective tubulin inhibitors as potential anti-trypanosomal agents.
    Lama R; Sandhu R; Zhong B; Li B; Su B
    Bioorg Med Chem Lett; 2012 Sep; 22(17):5508-16. PubMed ID: 22850214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel distamycin analogues that block the cell cycle of African trypanosomes with high selectivity and potency.
    Franco J; Scarone L; Comini MA
    Eur J Med Chem; 2020 Mar; 189():112043. PubMed ID: 31978782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and biological evaluation of selective tubulin inhibitors as anti-trypanosomal agents.
    Bobba V; Nanavaty V; Idippily ND; Zhao A; Li B; Su B
    Bioorg Med Chem; 2017 Jun; 25(12):3215-3222. PubMed ID: 28428042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pt-Fe ferrocenyl compounds with hydroxyquinoline ligands show selective cytotoxicity on highly proliferative cells.
    Rivas F; Medeiros A; Comini M; Suescun L; Rodríguez Arce E; Martins M; Pinheiro T; Marques F; Gambino D
    J Inorg Biochem; 2019 Oct; 199():110779. PubMed ID: 31351379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel 2,6-diketopiperazine-derived acetohydroxamic acids as promising anti-
    Fytas G; Zoidis G; Taylor MC; Kelly JM; Tsatsaroni A; Tsotinis A
    Future Med Chem; 2019 Jun; 11(11):1259-1266. PubMed ID: 31161793
    [No Abstract]   [Full Text] [Related]  

  • 15. Novel pyrrolobenzoxaboroles: design, synthesis, and biological evaluation against Trypanosoma brucei.
    Wu P; Zhang J; Meng Q; Nare B; Jacobs RT; Zhou H
    Eur J Med Chem; 2014 Jun; 81():59-75. PubMed ID: 24826816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New heterobimetallic ferrocenyl derivatives: Evaluation of their potential as prospective agents against trypanosomatid parasites and Mycobacterium tuberculosis.
    Rivas F; Medeiros A; Rodríguez Arce E; Comini M; Ribeiro CM; Pavan FR; Gambino D
    J Inorg Biochem; 2018 Oct; 187():73-84. PubMed ID: 30055398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trypanocidal activity of tetradentated pyridine-based manganese complexes is not linked to inactivation of superoxide dismutase.
    Steverding D; Kolosevska K; Sánchez-Moreno M
    Exp Parasitol; 2018 Sep; 192():1-5. PubMed ID: 30026114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. From Cells to Mice to Target: Characterization of NEU-1053 (SB-443342) and Its Analogues for Treatment of Human African Trypanosomiasis.
    Devine WG; Diaz-Gonzalez R; Ceballos-Perez G; Rojas D; Satoh T; Tear W; Ranade RM; Barros-Álvarez X; Hol WG; Buckner FS; Navarro M; Pollastri MP
    ACS Infect Dis; 2017 Mar; 3(3):225-236. PubMed ID: 28110521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of 2-(1H-imidazo-2-yl)piperazines as a new class of potent and non-cytotoxic inhibitors of Trypanosoma brucei growth in vitro.
    Ferrigno F; Biancofiore I; Malancona S; Ponzi S; Paonessa G; Graziani R; Bresciani A; Gennari N; Di Marco A; Kaiser M; Summa V; Harper S; Ontoria JM
    Bioorg Med Chem Lett; 2018 Dec; 28(23-24):3689-3692. PubMed ID: 30482621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lead optimization of selective tubulin inhibitors as anti-trypanosomal agents.
    Zhao A; Li Y; Orahoske CM; Schnur B; Sabbagh A; Zhang W; Li B; Su B
    Bioorg Med Chem; 2019 Apr; 27(8):1517-1528. PubMed ID: 30833159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.